Acanthamoeba keratitis cluster: An increase in Acanthamoeba keratitis in Australia

Clinical and Experimental Ophthalmology

Volumn 37, Issue 2, 2009, Pages 181-190

  Ku, Jae Yee ^a   Chan, Fiona M ^a   Beckingsale, Peter ^a,b,c  

^a PRINCESS ALEXANDRA HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c NONE   (Australia)

Author keywords

Acanthamoeba keratitis; Contact lens; Incidence

Indexed keywords

ACICLOVIR; AMPHOTERICIN; CHLORAMPHENICOL; CHLORHEXIDINE; CIPROFLOXACIN; DEXAMETHASONE; FLUOROMETHOLONE; KETOCONAZOLE; OFLOXACIN; PENTAMIDINE; POLY(HEXAMETHYLENEBIGUANIDE); POVIDONE IODINE; PREDNISOLONE; PREDNISOLONE SODIUM PHOSPHATE; PROPAMIDINE ISETHIONATE; RIFAMPICIN; SILICON; TOBRAMYCIN;

ACANTHAMOEBA; ACANTHAMOEBA KERATITIS; ADULT; ARTICLE; AUSTRALIA; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTACT LENS; CONTROLLED STUDY; ENUCLEATION; FEMALE; HERPES SIMPLEX KERATITIS; HUMAN; INCIDENCE; KERATOPLASTY; MALE; NONHUMAN; OUTPATIENT; RETROSPECTIVE STUDY; RISK FACTOR; TERTIARY HEALTH CARE;

ACANTHAMOEBA KERATITIS; ADULT; ANTIPROTOZOAL AGENTS; AUSTRALIA; CLUSTER ANALYSIS; CONTACT LENS SOLUTIONS; CONTACT LENSES, EXTENDED-WEAR; CONTACT LENSES, HYDROPHILIC; FEMALE; HOSPITALS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; VISUAL ACUITY; YOUNG ADULT;

EID: 65449147427     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2008.01910.x     Document Type: Article

References (55)

1. Nagington J. Amoebic infection of the eye. Lancet 1974; 2: 1537-40.
2. Khan N. Acanthamoeba: Biology and increasing importance in human health. FEMS Microbiol Rev 2005; 30: 564-95.
3. Stapleton F, Keay LJ, Sanfilippo PG, Katiyar S, Edwards KP, Naduvilath T. Relationship between climate, disease severity, and causative organism for contact lens-associated microbial keratitis in Australia. Am J Ophthalmol 2007; 144: 690-8.
4. Centers for disease control and prevention. Acanthamoeba keratitis associated with contact lenses - United States. MMWR 1986; 35: 405-8.
5. Stehr-Green J, Bailey T, Brandt F, Carr J, Bond W, Visvevara G. Acanthamoeba keratitis in soft contact lens wearers: A case-control study. JAMA 1987; 258: 57-60.
6. Joslin C, Tu E, McMahon T, Passaro D, Stayner L, Sugar J. Epidemiological characteristics of a Chicago-area Acanthamoeba keratitis outbreak. Am J Ophthalmol 2006; 147: 212-17.
7. Centers for disease control and prevention. Acanthamoeba keratitis -multiple states, 2005-2006. MMWR 2007; 56: 532-4.
8. Acharya NR, Lietman TM, Margolis TP. Parasites on the rise: A new epidemic of Acanthamoeba keratitis. Am J Ophthalmol 2007; 144: 292-3.
9. Thebpatiphat N, Hammersmith KM, Rocha F et al. Acanthamoeba keratitis, a parasite on the rise. Cornea 2007; 26: 701-6.
10. Joslin C, Tu E, Shoff M et al. The association of contact lens solution use and Acanthamoeba keratitis. Am J Ophthalmol 2007; 144: 169-80.
11. Khor WB, Aung T, Saw SM et al. An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. JAMA 2006; 295: 2867-73.
12. Centers for disease control and prevention. Update: Fusarium keratitis -United States, 2005-2006. MMWR 2006; 55: 563-4.
13. Centers for disease control and prevention. Fusarium keratitis -multiple states, 2006. MMWR 2006; 55: 400-1.
14. Chang D, Grang G, O'Donnell K et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA 2006; 296: 953-63.
15. Alfonso EC, Catu-Dibidox J, Munir WM et al. Insurgence of Fusarium keratitis associated with contact lens wear. Arch Ophthalmol 2006; 124: 941-7.
16. Snyder C. Lens care complications -where's the rub? Cont Lens Anterior Eye 2006; 29: 161-2.
17. Beatie TK, Tomlinson A, McFadyen AK. Attachment of Acanthamoeba to first- and second-generation silicone hydrogel contact lenses. Ophthalmology 2006; 113: 117-25.
18. Beatie T, Tomlinson A, McFadyen A, Seal D, Grimason A. Enhanced attachment of Acanthamoeba to extended-wear silicone hydrogel contact lenses: A new risk factor for infection? Ophthalmology 2003; 110: 765-71.
19. Beatie TK, Seal D, Tomlinson A, McFadyen A, Grimason A. Determination of amoebicidal activities of multipurpose contact lens solution by using a most probable number enumeration technique. J Clin Microbiol 2003; 41: 2992-3000.
20. Morgan P, Efron N, Woods C et al. International contact lens prescribing in 2005. Cont Lens Spectr 2006; 21: 35-9.
21. Stevenson R, Seal D. Has the introduction of multi-purpose solutions contributed to a reduced incidence of Acanthamoeba keratitis in contact lens wearers? A review. Cont Lens Anterior Eye 1998; 21: 89-92.
22. Gebauer A, McGhee CNJ, Crawford GJ. Severe microbial keratitis in temperate and tropical Western Australia. Eye 1996; 10: 575-80.
23. Green MD, Apel AJG, Naduvilath T, Stapleton F. Clinical outcomes of keratitis. Clin Exp Ophthalmol 2007; 35: 421-6.
24. Butler T, Males J, Robinson L et al. Six-year review of Acanthamoeba keratitis in New South Wales, Australia: 1997-2002. Clin Exp Ophthalmol 2005; 33: 41-6.
25. Kilvington S, Larkin DF. Acanthamoeba adherence to contact lenses and removal by cleaning agents. Eye 1990; 4: 589-93.
26. Cancrini G, Iori A, Mancino R. Acanthamoeba adherence to contact lenses, removal by rinsing procedures, and survival to some ophthalmic products. Parassitologia 1998; 40: 275-8.
27. Seal D. Acanthamoeba keratitis update -incidence, molecular epidemiology and new drugs for treatment. Eye 2003; 17: 893-905.
28. Radford C, Minassian D, Dart JK. Acanthamoeba keratitis in England and Wales: Incidence, outcome, and risk factors. Br J Ophthalmol 2002; 86: 536-42.
29. Beatie T, Tomlinson A, Seal D. Surface treatment or material characteristic: The reason for the high level of Acanthamoeba attachment to silicone hydrogel contact lenses. Eye Contact Lens 2003; 29: S40-S43.
30. Barr JT. Annual report contact lenses 2006. Cont Lens Spectr 2007; 26-33.
31. Hammersmith KM. Diagnosis and management of Acanthamoeba keratitis. Curr Opin Ophthalmol 2006; 17: 327-31.
32. Watt K, Swarbrick H. Microbial keratitis in overnight orthokeratology: review of the first 50 cases. Eye Contact Lens 2005; 31: 201-8.
33. Wilhelmus K. Acanthamoeba keratitis during orthokeratology. Cornea 2005; 24: 864-6.
34. Tzanetou K, Miltsakakis D, Droutsas D et al. Acanthamoeba keratitis and contact lens disinfecting solutions. Ophthalmologica 2006; 220: 238-41.
35. Hiti K, Walochnik J, Haller-Schober E, Faschinger C, Aspock H. Efficacy of contact lens storage solutions against different Acanthamoeba strains. Cornea 2006; 25: 423-7.
36. Hiti K, Walochnik J, Faschinger C, Haller-Schober E, Aspock H. One- and two-step hydrogen peroxide contact lens disinfection solutions against Acanthamoeba: How effective are they? Eye 2005; 19: 1301-5.
37. Hughes R, Kilvington S. Comparison of hydrogen peroxide contact lens disinfection systems and solutions against Acanthamoeba polyphaga. Antimicrob Agents Chemother 2001; 45: 2038-43.
38. Polat Z, Vural A, Cetin A. Efficacy of contact lens storage solutions against trophozoite and cyst of Acanthamoeba castellanii strain 1BU and their cytotoxic potential on corneal cells. Parasitol Res 2007; 101: 997-1001.
39. Borazjani RN, Kilvington S. Efficacy of multipurpose solutions against Acanthamoeba species. Cont Lens Anterior Eye 2007; 28: 169-75.
40. Shoff M, Rogerson A, Schatz S, Seal D. Variable responses of Acanthamoeba strains to three multipurpose lens cleaning solutions. Optom Vis Sci 2007; 84: 202-7.
41. Shih K, Hu J, Sibley M. The microbiological benefit of cleaning and rinsing contact lenses. Int Cont Lens Clin 1985; 12: 235-42.
42. Rosenthal R, Henry C, Schlech B. Contribution of regimen steps to disinfection of hydrophilic contact lenses. Cont Lens Anterior Eye 2004; 27: 149-56.
43. Claydon B, Efron N. Non-compliance in contact lens wear. Ophthal Physiol Optics 1994; 14: 356-64.
44. Christie C, Meyler J. Contemporary contact lens care products. Cont Lens Anterior Eye 1997; 20: S11-S17.
45. Illingworth CD, Cook SD. Acanthamoeba keratitis. Surv Ophthalmol 1998; 42: 493-508.
46. Larkin DF, Kilvington S, Dart JK. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 1992; 99: 185-91.
47. Lindquist T, Sher N, Doughman D. Clinical signs and medical therapy of early Acanthamoeba keratitis. Arch Ophthalmol 1998; 106: 73-7.
48. Bacon AS, Frazer DG, Dart JK, Matheson M, Ficker LA, Wright P. A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992. Eye 1993; 7: 719-25.
49. Tay-Kearney, Mcghee CNJ, Crawford GJ, Trown K. Acanthamoeba keratitis: A masquerade of presentation in six cases. Clin Exp Ophthalmol 1993; 21: 237-45.
50. Schuster FL, Visvesvara GS. Opportunistic amoebae: Challenges in prophylaxis and treatment. Drug Resist Updat 2004; 7: 41-51.
51. Hay J, Kirkness CM, Seal DV, Wright P. Drug resistance and Acanthamoeba keratitis: The quest for alternative antiprotozoal chemotherapy. Eye 1994; 8: 555-63.
52. Lim N, Goh D, Bunce C et al. Comparison of polyhexamethylene biguanide and chlorhexidine as monotherapy agents in the treatment of Acanthamoeba keratitis. Am J Ophthalmol 2007; 145: 130-5.
53. Ondarza R, Iturbe A, Hernández E. In vitro antiproliferative effects of neuroleptics, antimycotics and antibiotics on the human pathogens Acanthamoeba polyphaga and Naegleria fowleri. Arch Med Res 2006; 37: 723-9.
54. Singhal T, Bajpai A, Kalra V et al. Successful treatment of Acanthamoeba meningitis with combination oral antimicrobials. Padiatr Infect Dis J 2001; 20: 623-7.
55. Lim L, Coster DJ, Badenoch PR. Antimicrobial susceptibility of 19 Australian corneal isolates of Acanthamoeba. Clin Exp Ophthalmol 2000; 28: 119-24.